Share

    


In This Section

Home / Blurb / Discussion List

FDA Approves Pembrolizumab for Merkel Cell Carcinoma

Dec 19, 2018, 16:31 PM
URL:

On December 19, the Food and Drug Administration granted accelerated approval to pembrolizumab (Keytruda, Merck & Co. Inc.) for adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma (MCC).

Read the FDA press release here.

Posted 12/19/2018

Leave a comment